Cancer cells that express PD-L1 that contact with CD8 bearing PD-1 leads to a signaling cascade that results in reduction of TCR signaling, proliferation and cytotoxicity that prevents anti-tumor activity (Figure 3) (73). Here, CD8A is linked to neoplasm.